Renaissance Global Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 12, 2025, 3:01 am

Competitors of Renaissance Global Ltd

All Competitor Stocks of Renaissance Global Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:30 am

Below is a detailed analysis of the quarterly data for Renaissance Global Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 530.32 Cr.. The value appears strong and on an upward trend. It has increased from 514.40 Cr. (Mar 2025) to 530.32 Cr., marking an increase of 15.92 Cr..
• For Expenses, as of Jun 2025, the value is 494.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 476.23 Cr. (Mar 2025) to 494.11 Cr., marking an increase of 17.88 Cr..
• For Operating Profit, as of Jun 2025, the value is 36.21 Cr.. The value appears to be declining and may need further review. It has decreased from 38.17 Cr. (Mar 2025) to 36.21 Cr., marking a decrease of 1.96 Cr..
• For OPM %, as of Jun 2025, the value is 6.83%. The value appears to be declining and may need further review. It has decreased from 7.42% (Mar 2025) to 6.83%, marking a decrease of 0.59%.
• For Other Income, as of Jun 2025, the value is -7.36 Cr.. The value appears to be declining and may need further review. It has decreased from 2.58 Cr. (Mar 2025) to -7.36 Cr., marking a decrease of 9.94 Cr..
• For Interest, as of Jun 2025, the value is 11.19 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 12.35 Cr. (Mar 2025) to 11.19 Cr., marking a decrease of 1.16 Cr..
• For Depreciation, as of Jun 2025, the value is 8.33 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.39 Cr. (Mar 2025) to 8.33 Cr., marking a decrease of 0.06 Cr..
• For Profit before tax, as of Jun 2025, the value is 9.33 Cr.. The value appears to be declining and may need further review. It has decreased from 20.01 Cr. (Mar 2025) to 9.33 Cr., marking a decrease of 10.68 Cr..
• For Tax %, as of Jun 2025, the value is 29.26%. The value appears to be increasing, which may not be favorable. It has increased from -13.64% (Mar 2025) to 29.26%, marking an increase of 42.90%.
• For Net Profit, as of Jun 2025, the value is 6.60 Cr.. The value appears to be declining and may need further review. It has decreased from 22.73 Cr. (Mar 2025) to 6.60 Cr., marking a decrease of 16.13 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.59. The value appears to be declining and may need further review. It has decreased from 2.34 (Mar 2025) to 0.59, marking a decrease of 1.75.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:33 am

Growth

Last Updated: September 5, 2025, 1:05 pm

Balance Sheet

Last Updated: December 4, 2025, 1:53 am

Below is a detailed analysis of the balance sheet data for Renaissance Global Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 21.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,423.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,370.00 Cr. (Mar 2025) to 1,423.00 Cr., marking an increase of 53.00 Cr..
• For Borrowings, as of Sep 2025, the value is 713.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 661.00 Cr. (Mar 2025) to 713.00 Cr., marking an increase of 52.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 315.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 288.00 Cr. (Mar 2025) to 315.00 Cr., marking an increase of 27.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,473.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,340.00 Cr. (Mar 2025) to 2,473.00 Cr., marking an increase of 133.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 302.00 Cr.. The value appears to be declining and may need further review. It has decreased from 306.00 Cr. (Mar 2025) to 302.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Investments, as of Sep 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2025) to 126.00 Cr., marking an increase of 28.00 Cr..
• For Other Assets, as of Sep 2025, the value is 2,046.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,936.00 Cr. (Mar 2025) to 2,046.00 Cr., marking an increase of 110.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,473.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,340.00 Cr. (Mar 2025) to 2,473.00 Cr., marking an increase of 133.00 Cr..

Notably, the Reserves (1,423.00 Cr.) exceed the Borrowings (713.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Renaissance Global Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.68. This value is within the healthy range. It has increased from 7.59 (Mar 24) to 7.68, marking an increase of 0.09.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.63. This value is within the healthy range. It has increased from 7.54 (Mar 24) to 7.63, marking an increase of 0.09.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.68. This value is within the healthy range. It has decreased from 10.80 (Mar 24) to 9.68, marking a decrease of 1.12.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 129.72. It has increased from 119.47 (Mar 24) to 129.72, marking an increase of 10.25.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 129.72. It has increased from 119.47 (Mar 24) to 129.72, marking an increase of 10.25.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 194.07. It has decreased from 219.19 (Mar 24) to 194.07, marking a decrease of 25.12.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 15.61. This value is within the healthy range. It has decreased from 17.43 (Mar 24) to 15.61, marking a decrease of 1.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 12.80. This value is within the healthy range. It has decreased from 14.28 (Mar 24) to 12.80, marking a decrease of 1.48.
• For PBT / Share (Rs.), as of Mar 25, the value is 7.95. This value is within the healthy range. It has decreased from 8.88 (Mar 24) to 7.95, marking a decrease of 0.93.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.87. This value is within the healthy range. It has decreased from 7.66 (Mar 24) to 6.87, marking a decrease of 0.79.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.10. This value is within the healthy range. It has decreased from 7.53 (Mar 24) to 7.10, marking a decrease of 0.43.
• For PBDIT Margin (%), as of Mar 25, the value is 8.04. This value is below the healthy minimum of 10. It has increased from 7.94 (Mar 24) to 8.04, marking an increase of 0.10.
• For PBIT Margin (%), as of Mar 25, the value is 6.59. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 24) to 6.59, marking an increase of 0.08.
• For PBT Margin (%), as of Mar 25, the value is 4.09. This value is below the healthy minimum of 10. It has increased from 4.05 (Mar 24) to 4.09, marking an increase of 0.04.
• For Net Profit Margin (%), as of Mar 25, the value is 3.54. This value is below the healthy minimum of 5. It has increased from 3.49 (Mar 24) to 3.54, marking an increase of 0.05.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.65. This value is below the healthy minimum of 8. It has increased from 3.43 (Mar 24) to 3.65, marking an increase of 0.22.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 15. It has decreased from 6.30 (Mar 24) to 5.47, marking a decrease of 0.83.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.71. This value is below the healthy minimum of 10. It has decreased from 10.45 (Mar 24) to 8.71, marking a decrease of 1.74.
• For Return On Assets (%), as of Mar 25, the value is 3.25. This value is below the healthy minimum of 5. It has decreased from 3.57 (Mar 24) to 3.25, marking a decrease of 0.32.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has decreased from 0.44 (Mar 24) to 0.37, marking a decrease of 0.07.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.95. It has decreased from 1.07 (Mar 24) to 0.95, marking a decrease of 0.12.
• For Current Ratio (X), as of Mar 25, the value is 2.56. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 2.56, marking an increase of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has increased from 1.04 (Mar 24) to 1.30, marking an increase of 0.26.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 4. It has increased from 1.29 (Mar 24) to 2.15, marking an increase of 0.86.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.22. This value is within the healthy range. It has decreased from 3.23 (Mar 24) to 3.22, marking a decrease of 0.01.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.42. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 2.42.
• For Enterprise Value (Cr.), as of Mar 25, the value is 1,716.87. It has increased from 1,392.03 (Mar 24) to 1,716.87, marking an increase of 324.84.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.82, marking an increase of 0.16.
• For EV / EBITDA (X), as of Mar 25, the value is 10.25. This value is within the healthy range. It has increased from 8.31 (Mar 24) to 10.25, marking an increase of 1.94.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.45 (Mar 24) to 0.63, marking an increase of 0.18.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has increased from 0.83 (Mar 24) to 0.94, marking an increase of 0.11.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.45 (Mar 24) to 0.63, marking an increase of 0.18.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.05, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness